AgingResearch.News
Clinical and Translational Gastroenterology

Sodium Glucose Cotransporter 2 Inhibitor Use in Diabetic Patients With Cirrhosis Improves Liver-Related Outcomes and Survival

By Sajid Jalil, Khurram Bari, Khalid Mumtaz, Show 6 more authorsPaul Yien Kwo
Cohort study of 249,746 peopleInterventions

Independent replication

Paper

The paper

Sajid Jalil, Khurram Bari, Khalid Mumtaz, Show 6 more authorsPaul Yien Kwo

Stanford Medicine

Clinical and Translational Gastroenterology, 6 Aug 2026

doi.org/10.14309/ctg.0000000000001078PubMed 42561405

More on SGLT2 inhibitors